Paul J. Diaz - Sep 23, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Signature
By: Nathan A. Smith For: Paul J. Diaz
Stock symbol
MYGN
Transactions as of
Sep 23, 2021
Transactions value $
-$1,716,796
Form type
4
Date filed
9/27/2021, 07:39 PM
Previous filing
Aug 17, 2021
Next filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +445K +111.35% $0.00 845K Sep 23, 2021 Direct F1
transaction MYGN Common Stock Tax liability -$1.72M -49.4K -5.84% $34.76 796K Sep 23, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of performance-based restricted stock units (PSUs) initially granted on October 8, 2020, subject to accomplishment of pre-determined performance metrics. On September 23, 2021, the Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on September 23, 2021, and the remaining seventy-five percent (75%) of the earned PSUs will vest in three (3) installments of 25% each on the following dates: August 13, 2022, August 13, 2023, and August 13, 2024.
F2 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 23, 2021.